Shareholders meeting

Date: 27th August, 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol : SURAKSHA Dear Sir / Ma’am, Sub: Annual Report for FY 2025-26 including Notice for the 21st Annual General Meeting (AGM) Further to our letter dated 12th August, 2026, we hereby enclose, in terms of Regulations 30 and 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), as amended, the Annual Report of the Company for the financial year 2025-26, including Notice dated 12th August, 2026 convening the 21st Annual General Meeting (AGM) of the Company on 22nd September, 2026 which is being sent through electronic mode to the members whose e-mail addresses are registered with the Company / Registrar and Transfer Agent / Depository Participants. Further, in compliance with Regulation 36(1)(b) of the SEBI Listing Regulations, a letter containing the web-link of the website of the Company from where the Annual Report can be accessed, is being dispatched to those members whose email address is not registered with the Company / Registrar and Transfer Agent / Depository Participants. The Annual Report along with the notice of the 21st AGM of the Company are also available on the Company’s website at www.surakshanet.com . We request you to kindly take the above on record. Thank you. For Suraksha Diagnostic Limited Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Encl: As above Suraksha Diagnostic Limited CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750 Precision in Diagnostics, Trust in Care, Innovation in Healthcare Annual Report 2025-26 Empowering Healthcare with Contents Precision, Trust and Innovation Healthcare today is being reshaped by a new set of expectations: faster diagnosis, deeper clinical insight, personalised care and greater accessibility. In this evolving landscape, diagnostics is 02 Company 110 Financial becoming central to how healthcare is understood and delivered. 33 Overview 226 Statements At Suraksha Diagnostic, we are building for this future with a clear focus on precision, trust and innovation. 02 About Us Standalone 04 Year at a Glance 110 Independent Auditor’s Report Over the years, Suraksha has consistently cytogenetics, microarray, PCR and next- stayed ahead of the curve by bringing advanced generation sequencing, creating a powerful 06 Milestones 120 Balance Sheet diagnostic technologies to Eastern India. Today, platform for precision-led diagnostics. At the same 08 Joint Managing Directors’ Message 121 Statement of Profit and Loss that legacy is entering a transformative phase. time, the integration of globally recognised clinical 10 Performance Scorecard 122 Statement of Cash Flows Through strategic expansion and capability-led expertise and next-generation technologies is acquisitions, the Company is strengthening an further elevating the quality of care. 12 Changing Diagnostics Landscape 124 Statement of Changes in Equity integrated diagnostics ecosystem designed to 16 Our Diagnostic Services 125 Notes to Accounts deliver more specialised, technology-enabled and From advancing digital pathology capabilities to developing specialised oncology assays 18 How We Operate clinically advanced healthcare solutions. and embedding AI-enabled reporting across Consolidated 20 Quality Assurance The launch of Suraksha Genomics marks a defining radiology and pathology workflows, Suraksha 22 Enhancing Care through Technology 170 Independent Auditor’s Report milestone in this journey. With one of Eastern remains committed to empowering healthcare 178 Balance Sheet India’s first comprehensive genomics laboratories, with solutions that are clinically advanced, trusted, 24 Enabling Accessible and Connected Care Suraksha has expanded its capabilities across accessible and future-ready. 179 Statement of Profit and Loss 26 Our People 180 Statement of Cash Flows 27 Environment 181 Statement of Changes in Equity 28 Governance 30 Board of Directors 183 Notes to Accounts 32 Key Managerial Personnel 33 Awards and Recognition 34 Statutory 109 Reports Values that Guide Us 34 Notice of 21st Annual General Meeting At Suraksha, integrity in The benchmark for business is fundamental. Suraksha’s success is 45 Directors’ Report We are committed to customer satisfaction and maintaining transparency we aim to make diagnostic and upholding the services accessible Scan above QR code to know To know more about the Company, log on to highest standards and affordable for all, more about us https://www.surakshanet.com/ of business ethics in supporting early detection, all our dealings effective treatment and Forward looking statements long-term health by Some information in this report may contain forward-looking statements which include statements regarding Company’s expected financial position and creating a safe space for results of operations, business plans and prospects etc. and are generally identified by forward-looking words such as “believe,” “plan,” “anticipate,” accurate health evaluations “continue,” “estimate,” “expect,” “may,” “will” or other similar words. Forward-looking statements are dependent on assumptions or basis underlying such statements. We have chosen these assumptions or basis in good faith and we believe that they are reasonable in all material respects. However, we Precise diagnostic We recognise the value caution that actual results, performances or achievements could differ materially from those expressed or implied in such forward-looking statements. results are at the heart of of time and its optimum We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Suraksha’s approach utilisation for timely decision-making Suraksha Diagnostic Limited Corporate Overview Statutory Reports Financial Statements Annual Report 2025-26 About Us 01 04 Delivering Reassurance Through Medium-term To establish an accurate To have excellent and cost-effective financial results We aspire to metamorphise the Company into diagnostic facility Precision and Innovation the most reputable and cutting-edge diagnostic facility, providing precise, prompt, affordable 05 diagnostic services that will promote early 02 To achieve high detection and long-term wellness for everybody. To become the premier governance standards At Suraksha Diagnostic Limited, we diagnose with precision, scale and most reliable diagnostic facility in India with discipline and serve with care. Through an integrated network Long-term of laboratories, diagnostic centres and collection centres, we deliver Our vision is to be the most trusted and 03 To enhance the lives of people centred around Suraksha pathology, radiology and specialised healthcare solutions designed innovative diagnostic centre and set the To offer our patients standard for diagnostics in the future by utilising around accuracy, accessibility and speed. a better quality of state-of-the-art technology with knowledgeable 07 reporting service interpretation by expert professionals, accurate To harness the latest reporting and smooth patient experiences. With a strong presence across Eastern the vision of creating a comprehensive consultations, home collection services advancements in diagnostic and North-Eastern India, we remain diagnostic platform where patients could and polyclinic offerings. Over the years, technology to provide quick, focused on delivering accurate access both pathology and radiology our growth has remained rooted in one reliable results diagnostics, accessible hea [Showing first 8,000 characters — download PDF for full document]